US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 5.250
  • -0.350-6.25%
Trading Mar 26 11:18 ET
44.18MMarket Cap-0.38P/E (TTM)

About Karyopharm Therapeutics Company

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Company Profile

SymbolKPTI
Company NameKaryopharm Therapeutics
Listing DateNov 6, 2013
Issue Price16.00
Founded2008
CEOMr. Richard Paulson, M.B.A.
MarketNASDAQ
Employees279
Fiscal Year Ends12-31
Address85 Wells Avenue,Suite 210, 2nd floor
CityNewton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02459-3298
Phone1-617-658-0600

Company Executives

  • Name
  • Position
  • Salary
  • Richard Paulson, M.B.A.
  • Director, President and Chief Executive Officer
  • 2.63M
  • Sohanya Roshan Cheng, M.B.A.
  • Executive Vice President and Chief Commercial Officer
  • 1.19M
  • Lori Macomber, C.P.A.
  • Executive Vice President, Chief Financial Officer and Treasurer
  • --
  • Stuart Poulton
  • Executive Vice President and Chief Development Officer
  • 1.11M
  • Dr. Reshma Rangwala, M.D.,PhD
  • Head of Research, Executive Vice President and Chief Medical Officer
  • 1.23M
  • Kristin Abate
  • Vice President, Chief Accounting Officer, and Assistant Treasurer
  • --
  • Michael Mano, J.D.
  • Senior Vice President, General Counsel and Secretary
  • --
  • Christy J. Oliger
  • Independent Director
  • 138.33K
  • Dr. Mansoor Raza Mirza, M.D.
  • Independent Director
  • 208.33K
  • Garen G. Bohlin
  • Independent Director
  • 138.33K
  • Barry E. Greene
  • Lead Independent Director
  • 173.33K
  • Dr. Deepika Rachel Pakianathan
  • Independent Director
  • 148.33K
  • Dr. Zhen Su
  • Independent Director
  • 81.49K
  • Chen Schor, M.B.A.
  • Independent Director
  • 128.33K
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.